GERD Risk Higher With GLP-1s vs SGLT2s
October 06, 2025 Citation: Noh Y, Yin H, Yu OHY, Bitton A, Azoulay L. Glucagon-like peptide-1 receptor agonists and risk for gastroesophageal reflux disease in patients with type 2 diabetes: a population-based cohort study. Ann Intern Med. 2025;178:1268-1278. [Epub 15 July 2025]. doi:10.7326/ANNALS-24-03420 Source
GERD Risk Higher With GLP-1s vs SGLT2s Read More »
